Main Session
Sep 30
QP 12 - CNS 4: Quick Pitch: Trials, Toxicity, and Translational Updates in CNS

1070 - Induction-Concurrent Chemoradiotherapy with or without Camrelizumab for Postoperative Residual High-Grade Gliomas: An Open, Randomized, Phase II Clinical Study

04:45pm - 04:55pm PT
Room 307/308

Presenter(s)

Xiuling Luo, BS - Guizhou Cancer Hospital, Guiyang,